A phase 1/2 trial of BeOne…
A phase 1/2 trial of BeOne Medicines’ sonrotoclax has hit [...]
A phase 1/2 trial of BeOne Medicines’ sonrotoclax has hit [...]
Flagship Pioneering is boosting the clinical research capabilities of its [...]
The FDA has begun considering a noninvasive liver measurement as [...]
Plexium has raised $60.1 million, providing an infusion of cash [...]
A phase 1 study has linked Prothena’s anti-amyloid beta antibody [...]
As obesity pioneer Novo Nordisk loses ground in the race [...]
Mere months after its cancer blockbuster hopeful topped Bayer’s Stivarga [...]
Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on [...]
Wugen has raised $115 million, tapping a Fidelity-led syndicate to [...]
Right on the heels of a similar deal, Fosun Pharma [...]